BOC Group: Ohmeda (A) Harvard Case Solution & Analysis

President of Ohmeda, a wholly-owned Group company BOC, plans to grow the company's sales of medical equipment from the $ 95 million in 1985 to $ 158 million over five years, focusing on the sale of "high-tech" equipment. At the same time, the president expects to sell medical devices in the business-Ohmeda ($ 22 million in sales), and transfer its medical business gas ($ 27.2 million in sales) in the other business units of the Group BOC. Changes in products Ohmeda, combined with the planned increase in medical equipment to bring to the President to review the system's marketing Ohmeda. New strategic direction requires its review of the role of direct sales Ohmeda and cover dealer sales. However, he estimates the economy out of the three options. 1) extends to the current system Ohmeda, 2) elimination of coverage dealer sales, and 3) specialized vendors by product group "Hide
by Rowland T. Moriarty Jr., Gordon Schwartz Source: Harvard Business School 23 pages. Publication Date: September 25, 1986. Prod. #: 587080-PDF-ENG

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.